Pharmacogenetics and Physiologic Disposition of Drugs
| Topic | Lecturer |
| Introduction | Dr. J. T. Callaghan |
| Introduction to Pharmacokinetics | Dr. R. F. Bergstrom |
| PK/PD | Dr. R. F. Bergstrom |
| Pharmacokinetics Basic Concepts and Applications | Dr. S. Hall |
| Phase I Metabolism and Enzymology (System) (1) | Dr. A. Borel |
| Role of Modeling and Simulation in Drug Development | Dr. V. Sinha |
| Drug Transporters | Dr. K. Hilgren |
| Renal Aspects of Drug Disposition | Dr. J. Voelker |
| Phase I Metabolism and Enzymology (System) (II) | Dr. J. Grace |
| Phase II Metabolism and Enzymology (GT&ST) | TBA |
| Understanding Molecular Biology | Dr. T. Skaar |
| Inhibition | Dr. D. Jones |
| Genetic Modulation of Drug Metabolism (Clinical) | Dr. J. T. Callaghan |
| Induction | Dr. S. Wrighton |
| In vitro Drug Metabolism Methodology | Mrs. Barb Ring |
| Metabolism Studies in Drug Discovery and Development (Why, When and How) | Dr. C. McMillian |
| Toxicologic Consequences of Drug Metabolilsm | Dr. J. Stevens |
| Clinical Significance of Drug Metabolsim | Dr. J. T. Callaghan |
| Drug Measurement I - Principles of Chromatography | Dr. M. P. Knadler |
| Pharmacogenetics of Receptors and Signaling Systems | Dr. D. Flockhart |
| Surrogates and Biomarkers | Dr. D. Flockhart |
| LC/MS, NMR and New Techniques in Drug Metabolism | Dr. A. Chaudhary |
| Drug Measurement II - Radio- and stable-isotopes | Dr. N. Faridt |
| Summary and Review | Dr. S. Hall |
